Herein, we comprehensively investigate the ability of the novel CHK1 inhibitor MU380 [19], a nontrivial analog of SCH900776 [33], to potentiate the efficacy of GEM in DR PCa models (Fig. S11A). This evidence concerns the gene CHEK1 and posterior cortical atrophy.